Gain Therapeutics, Inc. (GANX) Insider Trading

Name: Gain Therapeutics, Inc. (GANX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 17, 2026): GOLDSTEIN DOV A MD (Director): Grant/Award of 25,000 shares.

Get alerted when insiders trade GANX

Email address

Loading company data...

Beta

Loading company details...

Beta